| Literature DB >> 28928904 |
Dorota Rogińska1, Miłosz P Kawa1, Ewa Pius-Sadowska1, Renata Lejkowska1, Karolina Łuczkowska1, Barbara Wiszniewska2, Kai Kaarniranta3,4, Jussi J Paterno3,4, Christian A Schmidt5, Bogusław Machaliński1, Anna Machalińska2,6.
Abstract
The aim of the study was to investigate the influence of complement component C3 global depletion on the biological structure and function of the aged retina. In vivo morphology (OCT), electrophysiological function (ERG), and the expression of selected oxidative stress-, apoptosis-, and autophagy-related proteins were assessed in retinas of 12-month-old C3-deficient and WT mice. Moreover, global gene expression in retinas was analyzed by RNA arrays. We found that the absence of active C3 was associated with (1) alleviation of the age-dependent decrease in retinal thickness and gradual deterioration of retinal bioelectrical function, (2) significantly higher levels of antioxidant enzymes (catalase and glutathione reductase) and the antiapoptotic survivin and Mcl-1/Bak dimer, (3) lower expression of the cellular oxidative stress marker-4HNE-and decreased activity of proapoptotic caspase-3, (4) ameliorated retinal autophagic activity with localization of ubiquitinated protein conjugates commonly along the retinal pigment epithelium (RPE) layer, and (5) significantly increased expression of several gene sets associated with maintenance of the physiological functions of the neural retina. Our findings shed light on mechanisms of age-related retinal alterations by identifying C3 as a potential therapeutic target for retinal aging.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28928904 PMCID: PMC5591916 DOI: 10.1155/2017/5306790
Source DB: PubMed Journal: Oxid Med Cell Longev ISSN: 1942-0994 Impact factor: 6.543
Figure 1Functional and morphological evaluation of aged retinas from C3−/− and WT mice. (a) The representative rod, mixed rod-cone, and cone responses, as well as oscillatory potentials (OPs), recorded from 12-month-old C3-deficient (C3-def) and WT mice are shown. Changes in the retinal bioelectrical response during aging are presented as a percentage value calculated for each individual 1-year-old mice in reference to the b-wave amplitude measurements obtained from 3-month-old mice (considered 100%). The results are shown as mean ± SD (n = 10 mice per group). The ERG recordings at 12 months of age were reduced in both C3−/− and WT mice (∗∗p < 0.01 for scotopic and photopic conditions); however, when analyzing mixed rod-cone responses and OPs, the b-wave amplitudes in C3-deficient mice were significantly higher (∗∗p < 0.01) compared to age-matched WT animals. (b) The representative in vivo SD-OCT retinal scans and H&E-stained images of 3- and 12-month-old C3-def and WT mice are shown. The scale bar is 20 μm. (c) Spectral domain optical coherence tomography was used to assess the changes in retinal morphology and thickness over time. Changes in retinal thickness are presented as a percentage value calculated for each individual 1-year-old mice in reference to measurements obtained from 3-month-old mice (considered 100%). The results are shown as mean ± SD (n = 10 mice per group). Aged retinas of both C3-def and WT mice showed the signs of declined thickness (∗∗p < 0.01); however, this process was more profound in WT mice (∗∗p < 0.01). (d) Immunofluorescence analysis of complement component C3 in aged WT retinas revealed deposition of the protein in the sub-RPE region. The sections from 12-month-old C3-deficient animals served as a staining control. The scale bar is 20 μm.
Figure 2Evaluation of oxidative stress markers and apoptotic activity in the retinas of aged C3-deficient and WT mice. (a) Western blot and densitometry analysis of 4HNE, catalase, glutathione reductase (GSR), and β-actin, which served as an internal control. Immunoblot images are representative of three independent experiments yielding similar results. The protein expression level of the 4HNE, catalase, and GSR was quantified in comparison to that of β-actin and shown as mean ± SD (n = 14 eyes per group). 4HNE-modified proteins, an oxidative stress marker, were detected in both 12-month-old C3-def and WT mice, although the 4HNE/β-actin ratio was significantly lower in the retinas collected from C3-def mice (∗∗p < 0.01). Moreover, catalase and GSR levels, which represent antioxidant enzymes, were considerably higher in C3-deficient mice (∗∗p < 0.01). (b) Luminex multiplex fluorescent bead-based immunoassay was used to evaluate protein expression level of survivin, Mcl-1/Bak dimer, and active caspase-3 in retinal lysates. To standardize the final concentration values, the obtained data was normalized to the total protein concentration. The results are shown as mean ± SD (n = 14 eyes per group). C3-def mice demonstrated higher rates of survivin and Mcl-1/Bak dimer (∗∗p < 0.01), which represent antiapoptotic proteins (∗p < 0.05). The rates of active caspase-3 were considerably lower in C3-def mice (∗p < 0.05) as compared to age-matched control mice.
Figure 3Evaluation of the autophagy markers in the retinas of aged C3-deficient and WT mice. (a) Western blot and densitometry analysis of ubiquitin, LC3B, p62, and β-actin, which served as an internal control. Immunoblot images are representative of three independent experiments yielding similar results. The protein expression level of the ubiquitin and p62 was quantified in comparison to that of β-actin. The LC3B protein level is presented as a LC3B-II/LC3B-I ratio. The results are shown as mean ± SD (n = 14 eyes per group). Western blot analysis in the retinas collected from C3-def mice demonstrates strong expression of the ubiquitinated proteins (∗∗p < 0.01) and higher LC3B-II/I ratio (∗p < 0.05) together with a decrease in p62 level (∗∗p < 0.01), compared to that from age-matched control mouse retinas. (b) Immunofluorescence staining of ubiquitin protein in the retinas of the 12-month-old C3-def and WT mice confirms the decreased expression of ubiquitin in RPE cells of WT mice. The scale bar is 10 μm.
List of top 25 up- and downregulated genes in 12-month-old C3-deficient mice. Genes are ranked according to the expression fold difference—the gene from the top of the list is the most upregulated and the gene from the bottom of the list is the most downregulated in C3-deficient mice compared to control animals.
| Direction in C3-def | Gene symbol | Gene name | Probe ID | Entrez Gene ID | Fold change |
|---|---|---|---|---|---|
| Up | Serpine3 | Serpin peptidase inhibitor, clade E (nexin, plasminogen inhibitor) | 17301155 | 319433 | 8.13 |
| Up | Akr1e1 | Aldo-keto reductase family 1, member E1 | 17290301 | 56043 | 4.41 |
| Up | Edv | Endogenous sequence related to the Duplan murine retrovirus | 17548311 | 13623 | 4.28 |
| Up | Rpl29 | Ribosomal protein 29 | 17521204 | 19944 | 4.23 |
| Up | Abhd14a | Abhydrolase domain containing 14A | 17530686 | 68644 | 4.02 |
| Up | Gatc | Glutamyl-tRNA (Gln) amidotransferase, subunit C homolog | 17451721 | 384281 | 3.70 |
| Up | Cplx4 | Complexin 4 | 17355086 | 225644 | 3.33 |
| Up | Uprt | Uracil phosphoribosylotransferase (FUR1) homolog | 17537003 | 331487 | 3.07 |
| Up | H2-T22 | Histocompatibility 2, T region locus 22 | 17344593 | 15039 | 3.02 |
| Up | Mzt1 | Mitotic spindle organizing protein 1 | 17309065 | 76789 | 3.01 |
| Up | Mpc1 | Mitochondrial pyruvate carrier 1 | 17284037 | 55951 | 2.81 |
| Up | Adam4 | A disintegrin and metallopeptidase domain 4 | 17282343 | 11498 | 2.78 |
| Up | Rab6b | RAB6B, member RAS oncogene family | 17520922 | 270192 | 2.75 |
| Up | Pcdhb18 | Protocadherin beta 18 | 17349930 | 93889 | 2.67 |
| Up | Cdh12 | Cadherin 12 | 17310550 | 215654 | 2.65 |
| Up | Fabp4 | Fatty acid-binding protein 4, adipocyte | 17404091 | 11770 | 2.59 |
| Up | Pde6c | Phosphodiesterase 6C, cGMP specific, cone, alpha prime | 17359118 | 110855 | 2.59 |
| Up | Fam213a | Family with sequence similarity 213, member A | 17305221 | 70564 | 2.59 |
| Up | Nefl | Neurofilament, light peptide | 17301582 | 18039 | 2.57 |
| Up | Akap6 | A kinase (PRKA) anchor protein 6 | 17275436 | 238161 | 2.57 |
| Up | Aldh1a1 | Aldehyde dehydrogenase family 1, subfamily A1 | 17358103 | 11668 | 2.55 |
| Up | Hdac1 | Histone deacytelase 1 | 17430397 | 433759 | 2.55 |
| Up | Rpgrip1 | Retinitis pigmentosa Gtpase regulator-interacting protein 1 | 17299715 | 77945 | 2.54 |
| Up | Rgs9bp | Regulator of G protein signaling 9 binding protein | 17489809 | 243923 | 2.50 |
| Down | Il1f9 | Interleukin 1 family, member 9 | 17367652 | 215257 | −5.53 |
| Down | Igkv1-110 | Immunoglobulin kappa variable 1-110 | 17459338 | 381777 | −5.64 |
| Down | Muc5b | Mucin 5, subtype B, tracheobronchial | 17485098 | 74180 | −6.06 |
| Down | Krt10 | Keratin 10 | 17269064 | 16661 | −6.11 |
| Down | Krtdap | Keratinocyte differentiation-associated protein | 17476557 | 64661 | −6.39 |
| Down | Sprr2f | Small proline-rich protein 2F | 17399876 | 20760 | −6.46 |
| Down | Ighg1 | Immunoglobulin heavy constant gamma 1 (G1m marker) | 17284339 | 16017 | −6.48 |
| Down | Ighj3 | Immunoglobulin heavy joining 3 | 17284356 | 777655 | −7.50 |
| Down | Ighg2b | Immunoglobulin heavy constant gamma 2B | 17284334 | 16016 | −7.73 |
| Down | Igkj1 | Immunoglobulin kappa joining 1 | 17459415 | 110759 | −8.18 |
| Down | Defb6 | Defensin beta 6 | 17499602 | 116746 | −8.34 |
| Down | Igj | Immunoglobulin joining chain | 17449447 | 16069 | −8.53 |
| Down | Cryba4 | Crystalline, beta A4 | 17451195 | 12959 | −8.55 |
| Down | Ltf | Lactotransferrin | 17522555 | 17002 | −8.70 |
| Down | Cnfn | Cornifelin | 17487919 | 72383 | −8.97 |
| Down | Ighj1 | Immunoglobulin heavy joining 1 | 17284360 | 777648 | −10.53 |
| Down | Klk13 | Kallikrein-related peptidase 13 | 17477191 | 626834 | −10.71 |
| Down | Lgsn | Lengsin, lens protein with glutamate synthetase domain | 17211533 | 266744 | −11.56 |
| Down | Lce1c | Late cornified envelope 1C | 17399899 | 73719 | −12.31 |
| Down | Igh-VJ558 | Immunoglobulin heavy chain (J558 family) | 17284314 | 16061 | −13.62 |
| Down | Rps13 | Ribosomal protein S13 | 17493182 | 68052 | −14.76 |
| Down | Igkv4-53 | Immunoglobulin kappa variable 4-53 | 17459423 | 546213 | −16.50 |
| Down | Ighj4 | Immunoglobulin heavy joining 4 | 17284354 | 777656 | −18.58 |
| Down | Ppbp | Proplatelet basic protein | 17438963 | 57349 | −21.02 |
| Down | Reg3g | Regenerating islet-derived 3 gamma | 17467973 | 19695 | −25.95 |
Figure 4Overrepresented biological process assigned according to Gene Ontology (GO) classification in the retinas of aged C3-deficient mice compared to WT mice. Groups of genes fulfilling criteria: adjusted p value < 0.05, method = Benjamini, and minimum number of genes per group = 5, are presented in a graph, where bubble size indicates the number of genes represented in corresponding annotation and the condition of these genes in terms of their up- and downregulation.
Figure 5Gene set enrichment analysis (GSEA) of the retinas from aged C3-deficient mice compared to WT mice. Diagrams represent selected gene sets enriched in C3-deficient mice (secretory pathway, phototransduction, and neurological system process) and WT control animals (morphogenesis of an epithelium, immune response, and inflammatory response).
Top gene sets enriched in 12-month-old C3-deficient and WT mice. Gene sets are ranked according to the normalized enrichment score (NES)—the gene set from the top of the list is the most enriched in C3-def mice and the gene set from the bottom of the list is the most enriched in WT mice.
| Direction in C3-def | Gene set | Size | ES | NES | NOM | FDR |
|---|---|---|---|---|---|---|
| Up | Secretory pathway | 83 | 0.54 | 2.02 | 0.000 | 0.014 |
| Up | Synaptic transmission | 164 | 0.48 | 1.98 | 0.000 | 0.021 |
| Up | Transmission of nerve impulse | 179 | 0.47 | 1.96 | 0.000 | 0.021 |
| Up | Neurological system process | 359 | 0.42 | 1.90 | 0.000 | 0.038 |
| Up | Nuclear export | 32 | 0.60 | 1.84 | 0.000 | 0.076 |
| Up | Golgi vesicle transport | 48 | 0.54 | 1.81 | 0.000 | 0.097 |
| Up | Brain development | 47 | 0.53 | 1.80 | 0.000 | 0.090 |
| Up | Secretion by cell | 114 | 0.45 | 1.79 | 0.000 | 0.101 |
| Up | Exocytosis | 24 | 0.60 | 1.76 | 0.007 | 0.126 |
| Up | Synaptogenesis | 15 | 0.66 | 1.75 | 0.009 | 0.115 |
| Up | RNA export from nucleus | 19 | 0.63 | 1.73 | 0.003 | 0.131 |
| Up | Regulation of cell-cell adhesion | 9 | 0.77 | 1.72 | 0.007 | 0.135 |
| Up | Microtubule-based movement | 16 | 0.64 | 1.71 | 0.007 | 0.150 |
| Up | Phototransduction | 13 | 0.66 | 1.70 | 0.007 | 0.154 |
| Up | Nervous system development | 352 | 0.37 | 1.67 | 0.000 | 0.187 |
| Up | Chromosome organization and biogenesis | 118 | 0.42 | 1.67 | 0.000 | 0.184 |
| Up | NLS-bearing substrate import into nucleus | 12 | 0.67 | 1.67 | 0.017 | 0.175 |
| Up | Synapse organization and biogenesis | 20 | 0.60 | 1.66 | 0.022 | 0.174 |
| Up | Establishment of cellular localization | 343 | 0.36 | 1.63 | 0.000 | 0.216 |
| Up | Central nervous system development | 116 | 0.41 | 1.62 | 0.000 | 0.220 |
| Up | Intracellular transport | 272 | 0.37 | 1.62 | 0.001 | 0.196 |
| Up | Cellular localization | 360 | 0.36 | 1.62 | 0.000 | 0.194 |
| Up | Sensory perception | 181 | 0.38 | 1.61 | 0.001 | 0.206 |
| Up | Vesicle-mediated transport | 189 | 0.38 | 1.58 | 0.000 | 0.216 |
| Up | Secretion | 175 | 0.38 | 1.57 | 0.000 | 0.213 |
| Up | Organelle organization and biogenesis | 453 | 0.33 | 1.53 | 0.000 | 0.245 |
| Down | Translation | 163 | −0.34 | −1.51 | 0.003 | 0.241 |
| Down | Response to external stimulus | 297 | −0.33 | −1.58 | 0.000 | 0.216 |
| Down | Immune system process | 304 | −0.34 | −1.61 | 0.000 | 0.194 |
| Down | Regulation of protein modification process | 41 | −0.47 | −1.61 | 0.007 | 0.200 |
| Down | Positive regulation of signal transduction | 123 | −0.38 | −1.63 | 0.000 | 0.181 |
| Down | Regulation of immune system process | 64 | −0.43 | −1.68 | 0.003 | 0.158 |
| Down | Response to wounding | 182 | −0.38 | −1.68 | 0.000 | 0.158 |
| Down | Response to biotic stimulus | 107 | −0.41 | −1.69 | 0.000 | 0.155 |
| Down | Regulation of protein amino acid phosphorylation | 28 | −0.54 | −1.70 | 0.005 | 0.159 |
| Down | Cytokine- and chemokine-mediated signaling pathway | 22 | −0.58 | −1.73 | 0.009 | 0.127 |
| Down | Developmental growth | 11 | −0.71 | −1.75 | 0.007 | 0.113 |
| Down | Regulation of protein import into nucleus | 16 | −0.64 | −1.75 | 0.009 | 0.114 |
| Down | Epithelial cell differentiation | 9 | −0.76 | −1.76 | 0.010 | 0.115 |
| Down | Immune response | 214 | −0.38 | −1.76 | 0.000 | 0.120 |
| Down | Inflammatory response | 123 | −0.42 | −1.76 | 0.000 | 0.128 |
| Down | Multiorganism process | 134 | −0.41 | −1.76 | 0.000 | 0.134 |
| Down | Regulation of immune response | 32 | −0.54 | −1.76 | 0.005 | 0.143 |
| Down | Regulation of phosphorylation | 46 | −0.51 | −1.81 | 0.000 | 0.097 |
| Down | Positive regulation of epithelial cell proliferation | 10 | −0.75 | −1.84 | 0.000 | 0.077 |
| Down | Morphogenesis of an epithelium | 15 | −0.71 | −1.88 | 0.005 | 0.050 |
| Down | Response to other organisms | 72 | −0.50 | −1.94 | 0.000 | 0.023 |
| Down | Tissue development | 133 | −0.47 | −1.97 | 0.000 | 0.016 |
| Down | Defense response | 239 | −0.43 | −1.98 | 0.000 | 0.015 |
| Down | Detection of biotic stimulus | 10 | −0.83 | −2.04 | 0.000 | 0.010 |
| Down | Acute inflammatory response | 11 | −0.85 | −2.05 | 0.000 | 0.009 |
| Down | Keratinocyte differentiation | 14 | −0.77 | −2.08 | 0.000 | 0.005 |
| Down | Response to bacterium | 28 | −0.67 | −2.12 | 0.000 | 0.001 |
| Down | Ectoderm development | 76 | −0.58 | −2.23 | 0.000 | 0.001 |
| Down | Epidermis development | 67 | −0.62 | −2.37 | 0.000 | 0.000 |